EPM Group
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1600 Webster St Apt 407, San Francisco, ...Phone Number
(323) 307-2111Website
www.epmip.comRevenue
<$5 MillionIndustry
About EPM Group
EPM Group Org Chart
Is EPM Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if EPM Group is spiking on competitors!
Check if EPM Group has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when EPM Group launches new products
Earning: See what the market has to say on EPM Group recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at EPM Group
Click to see if EPM Group had a recent Job posting/layoffs
EPM Group, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once EPM Group has new funding data
Recommended Actions
Reach out to Masked Content who joined EPM Group as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
EPM Group is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EPM Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EPM Group.
EPM Group Tech Stack
A closer look at the technologies used by EPM Group
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding EPM Group
EPM Therapeutics is a biotechnology company focused on developing synthetic cannabinoid acid derivatives, particularly EPM301, to address hyperphagia in patients with Prader-Willi Syndrome (PWS). Founded in 2017, the company aims to improve the quality of life for patients and their caregivers through innovative research and drug development. EPM30... Read More